Cargando…
Dominant drug targets suppress the emergence of antiviral resistance
The emergence of drug resistance can defeat the successful treatment of pathogens that display high mutation rates, as exemplified by RNA viruses. Here we detail a new paradigm in which a single compound directed against a ‘dominant drug target’ suppresses the emergence of naturally occurring drug-r...
Autores principales: | Tanner, Elizabeth J, Liu, Hong-mei, Oberste, M Steven, Pallansch, Mark, Collett, Marc S, Kirkegaard, Karla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270081/ https://www.ncbi.nlm.nih.gov/pubmed/25365453 http://dx.doi.org/10.7554/eLife.03830 |
Ejemplares similares
-
Premature polyadenylation of MAGI3 produces a dominantly-acting oncogene in human breast cancer
por: Ni, Thomas K, et al.
Publicado: (2016) -
Vive la résistance!
por: Sandler, Steven J
Publicado: (2014) -
A new role for a tumor-suppressing protein
por: Setton, Jeremy S, et al.
Publicado: (2018) -
Evolution of extreme resistance to ionizing radiation via genetic adaptation of DNA repair
por: Byrne, Rose T, et al.
Publicado: (2014) -
Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis
por: Zhang, Cen, et al.
Publicado: (2016)